Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma
These findings suggest <i>SEMA7A</i> as a candidate for further research in ACC biology and a candidate for cancer therapy, as well as a potential prognosis biomarker for ACC patients.
Authors
- Sudhir Varma (ORCID: https://orcid.org/0000-0002-4096-4782)
- Nitin Roper (ORCID: https://orcid.org/0000-0002-6514-5468)
- Christophe E. Redon (ORCID: https://orcid.org/0000-0003-2799-2778)
- Fathi Elloumi (ORCID: https://orcid.org/0009-0007-7116-508X)
- Augustin Luna (ORCID: https://orcid.org/0000-0001-5709-371X)
- Jaydira Del Rivero (ORCID: https://orcid.org/0000-0001-9710-4030)
- Yves Pommier (ORCID: https://orcid.org/0000-0002-3108-0758)
- Mirit I. Aladjem (ORCID: https://orcid.org/0000-0002-1875-3110)
- Yilun Sun (ORCID: https://orcid.org/0000-0002-6249-2704)
- Anjali Dhall (ORCID: https://orcid.org/0000-0002-0400-2084)
- Daiki Taniyama (ORCID: https://orcid.org/0000-0001-5388-4581)
- William C. Reinhold (ORCID: https://orcid.org/0000-0001-5513-9323)
- Lauren Escobedo
- Suresh Kumar (ORCID: https://orcid.org/0000-0001-5013-358X)
Institutions
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- United States National Library of Medicine (US)
- EP Analytics (United States) (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Publication Details
- Journal
- Cancers
- Published
- 2025-06-21
- DOI
- https://doi.org/10.3390/cancers17132078
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute